Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-06-14 Option Award | 2024-06-18 5:00 pm | N/A 2034-06-14 | Olema Pharmaceuticals Inc. | OLMA | Garland J. Scott Director | 23,000 | $0 | 23,000 (Direct) | View |
2024-06-13 Option Award | 2024-06-14 4:46 pm | N/A 2034-06-12 | ALX ONCOLOGY HOLDINGS INC | ALXO | Garland J. Scott Director | 20,200 | $0 | 20,200 (Direct) | View |
2024-05-23 Option Award | 2024-05-28 6:48 pm | N/A 2034-05-22 | Day One Biopharmaceuticals Inc. | DAWN | Garland J. Scott Director | 32,335 | $0 | 32,335 (Direct) | View |
2023-10-16 Option Award | 2023-10-17 4:43 pm | N/A 2033-10-15 | Olema Pharmaceuticals Inc. | OLMA | Garland J. Scott Director | 35,867 | $0 | 35,867 (Direct) | View |
2023-06-22 Option Award | 2023-06-26 7:19 pm | N/A 2033-06-21 | Day One Biopharmaceuticals Inc. | DAWN | Garland J. Scott Director | 37,500 | $0 | 37,500 (Direct) | View |
2023-06-20 Option Award | 2023-06-22 4:30 pm | N/A 2033-06-19 | ALX ONCOLOGY HOLDINGS INC | ALXO | Garland J. Scott Director | 10,100 | $0 | 10,100 (Direct) | View |
2022-11-28 Option Award | 2022-11-29 4:32 pm | N/A 2032-11-28 | ALX ONCOLOGY HOLDINGS INC | ALXO | Garland J. Scott Director | 24,009 | $0 | 24,009 (Direct) | View |
2022-06-21 Option Award | 2022-06-23 6:09 pm | N/A 2032-06-20 | Day One Biopharmaceuticals Inc. | DAWN | Garland J. Scott Director | 28,700 | $0 | 28,700 (Direct) | View |
2022-06-01 Option Award | 2022-06-03 4:05 pm | N/A 2032-05-31 | Calithera Biosciences Inc. | CALA | Garland J. Scott Director | 20,000 | $0 | 20,000 (Direct) | View |
2021-08-16 Option Award | 2021-08-18 7:03 pm | N/A 2031-08-15 | Day One Biopharmaceuticals Inc. | DAWN | Garland J. Scott Director | 48,072 | $0 | 48,072 (Direct) | View |
Ownership | 2021-08-18 7:02 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Garland J. Scott Director | 0 | $0 | 0 (Direct) | View |
2021-06-11 Option Award | 2021-06-14 4:05 pm | N/A 2031-06-10 | Calithera Biosciences Inc. | CALA | Garland J. Scott Director | 20,000 | $0 | 20,000 (Direct) | View |
2020-07-31 Option Award | 2020-08-04 4:05 pm | N/A 2030-07-30 | Calithera Biosciences Inc. | CALA | Garland J. Scott Director | 40,000 | $0 | 40,000 (Direct) | View |
Ownership | 2020-07-14 4:05 pm | N/A N/A | Calithera Biosciences Inc. | CALA | Garland J. Scott Director | 0 | $0 | 0 (Direct) | View |
2020-06-18 Option Award | 2020-07-02 4:28 pm | N/A N/A | PORTOLA PHARMACEUTICALS INC | PTLA | Garland J. Scott President and CEO | 1,173 | $8.36 | 0 (Direct) | View |
2020-07-02 Disposition | 2020-07-02 4:28 pm | N/A N/A | PORTOLA PHARMACEUTICALS INC | PTLA | Garland J. Scott President and CEO | 773,799 | $0 | 0 (Direct) | View |
2020-07-02 Disposition | 2020-07-02 4:28 pm | N/A N/A | PORTOLA PHARMACEUTICALS INC | PTLA | Garland J. Scott President and CEO | 25,702 | $18 | 0 (Direct) | View |
2020-07-02 Disposition | 2020-07-02 4:28 pm | N/A 2030-01-30 | PORTOLA PHARMACEUTICALS INC | PTLA | Garland J. Scott President and CEO | 200,000 | $5.21 | 0 (Direct) | View |
2020-02-24 Option Award | 2020-02-26 8:14 pm | N/A 2023-02-24 | PORTOLA PHARMACEUTICALS INC | PTLA | Garland J. Scott President and CEO | 150,000 | $0 | 150,000 (Direct) | View |
2020-01-31 Option Award | 2020-02-04 6:54 pm | N/A 2030-01-30 | PORTOLA PHARMACEUTICALS INC | PTLA | Garland J. Scott President and CEO | 250,000 | $0 | 377,928 (Direct) | View |
2020-02-03 Tax Withholding | 2020-02-04 6:54 pm | N/A N/A | PORTOLA PHARMACEUTICALS INC | PTLA | Garland J. Scott President and CEO | 5,623 | $12.89 | 377,928 (Direct) | View |